You just read:

Daiichi Sankyo Announces Positive Top-line Results from Phase 3 Clinical Trial Evaluating Mirogabalin in Diabetic Peripheral Neuropathic Pain

News provided by

Daiichi Sankyo

Aug 31, 2017, 07:00 ET